Richard Jennings
Directeur Général chez Generate Life Sciences, Inc.
Profil
Richard Jennings currently works at Generate Life Sciences, Inc., as Chief Executive Officer, Generate Life Sciences Co., as Chief Executive Officer & Director, and US Fertility LLC, as Chief Executive Officer & Director from 2023.
Mr. Jennings received his undergraduate degree and Masters Business Admin degree from Harvard Business School.
Postes actifs de Richard Jennings
| Sociétés | Poste | Début |
|---|---|---|
Generate Life Sciences, Inc.
 Generate Life Sciences, Inc. Medical/Nursing ServicesHealth Services Generate Life Sciences, Inc. provides diagnostic services. The company is headquartered in San Francisco, CA. | Directeur Général | - |
Generate Life Sciences Co.
 Generate Life Sciences Co. Medical/Nursing ServicesHealth Services Part of The Cooper Cos., Inc., Generate Life Sciences Co. is a company that provides sperm and egg donation, newborn stem cell processing, genetic screening, medical device, and healthcare technology services. The company is based in Los Angeles, CA. The CEO of the company is Richard Jennings. Generate Life Sciences was acquired by CooperSurgical, Inc. on December 17, 2021 for $1,605 million. | Directeur Général | - |
US Fertility LLC
 US Fertility LLC Medical/Nursing ServicesHealth Services US Fertility LLC is the largest physician-owned and physician-led integrated network of top-tier IVF/fertility practices in the United States. US Fertility and Ovation Fertility, a national network of premier IVF laboratories, are united under a shared mission to deliver the joy of parenthood through advanced reproductive medicine and innovative science. US Fertility supports over 200 physicians by leveraging collective expertise, driving innovation, and providing advanced business and digital solutions that streamline and enhance the delivery of exceptional patient care. The company is based in Rockville, MD, and has subsidiaries in the United States. The company offers comprehensive fertility-market-focused non-clinical, administrative, and technical platforms that help domestic and international practices improve patient outcomes and increase profitability. The company has helped more than 225,000 individuals and couples build their families using assisted reproductive technology. Richard Jennings has been the CEO of the company since 2023. | Directeur Général | 01/01/2023 |
Formation de Richard Jennings
| Harvard Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Generate Life Sciences, Inc.
Generate Life Sciences, Inc. Medical/Nursing ServicesHealth Services Generate Life Sciences, Inc. provides diagnostic services. The company is headquartered in San Francisco, CA. | Health Services |
Generate Life Sciences Co.
Generate Life Sciences Co. Medical/Nursing ServicesHealth Services Part of The Cooper Cos., Inc., Generate Life Sciences Co. is a company that provides sperm and egg donation, newborn stem cell processing, genetic screening, medical device, and healthcare technology services. The company is based in Los Angeles, CA. The CEO of the company is Richard Jennings. Generate Life Sciences was acquired by CooperSurgical, Inc. on December 17, 2021 for $1,605 million. | Health Services |
US Fertility LLC
US Fertility LLC Medical/Nursing ServicesHealth Services US Fertility LLC is the largest physician-owned and physician-led integrated network of top-tier IVF/fertility practices in the United States. US Fertility and Ovation Fertility, a national network of premier IVF laboratories, are united under a shared mission to deliver the joy of parenthood through advanced reproductive medicine and innovative science. US Fertility supports over 200 physicians by leveraging collective expertise, driving innovation, and providing advanced business and digital solutions that streamline and enhance the delivery of exceptional patient care. The company is based in Rockville, MD, and has subsidiaries in the United States. The company offers comprehensive fertility-market-focused non-clinical, administrative, and technical platforms that help domestic and international practices improve patient outcomes and increase profitability. The company has helped more than 225,000 individuals and couples build their families using assisted reproductive technology. Richard Jennings has been the CEO of the company since 2023. | Health Services |
